| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |